Rajiv Gandhi

Hester Biosciences Q2 and H1 FY22 Net Profit Up by 16% and 35%

Domestic sales have registered a growth of 21% in Q2 FY22 and 38% in H1FY22. There is marginal decrease in export sales in Q2 and H1 FY22. Export orders are affected due to restricted cargo movements globally.